GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKGAF) » Definitions » Piotroski F-Score

Merck KGaA (Merck KGaA) Piotroski F-Score : 5 (As of Apr. 25, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Merck KGaA Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Merck KGaA has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Merck KGaA's Piotroski F-Score or its related term are showing as below:

MKGAF' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 9
Current: 5

During the past 13 years, the highest Piotroski F-Score of Merck KGaA was 9. The lowest was 4. And the median was 6.


Merck KGaA Piotroski F-Score Historical Data

The historical data trend for Merck KGaA's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Piotroski F-Score Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 6.00 9.00 7.00 5.00

Merck KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 6.00 6.00 6.00 5.00

Competitive Comparison of Merck KGaA's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was 852.248 + 762.73 + 788.687 + 639.04 = $3,043 Mil.
Cash Flow from Operations was 913.276 + 673.889 + 1339.381 + 1148.31 = $4,075 Mil.
Revenue was 5667.024 + 5744.312 + 5520.811 + 5697.928 = $22,630 Mil.
Gross Profit was 3554.604 + 3426.869 + 3213.447 + 3160.305 = $13,355 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(51414.195 + 52073.876 + 52851.571 + 53261.473 + 52884.406) / 5 = $52497.1042 Mil.
Total Assets at the begining of this year (Dec22) was $51,414 Mil.
Long-Term Debt & Capital Lease Obligation was $10,075 Mil.
Total Current Assets was $13,515 Mil.
Total Current Liabilities was $9,486 Mil.
Net Income was 969.163 + 916.49 + 913.861 + 693.856 = $3,493 Mil.

Revenue was 5724.67 + 5885.835 + 5748.515 + 5995.763 = $23,355 Mil.
Gross Profit was 3536.344 + 3656.448 + 3622.772 + 3576.271 = $14,392 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(51256.497 + 50919.604 + 51497.886 + 50428.713 + 51414.195) / 5 = $51103.379 Mil.
Total Assets at the begining of last year (Dec21) was $51,256 Mil.
Long-Term Debt & Capital Lease Obligation was $9,746 Mil.
Total Current Assets was $12,925 Mil.
Total Current Liabilities was $10,078 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Merck KGaA's current Net Income (TTM) was 3,043. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Merck KGaA's current Cash Flow from Operations (TTM) was 4,075. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=3042.705/51414.195
=0.05918025

ROA (Last Year)=Net Income/Total Assets (Dec21)
=3493.37/51256.497
=0.06815468

Merck KGaA's return on assets of this year was 0.05918025. Merck KGaA's return on assets of last year was 0.06815468. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Merck KGaA's current Net Income (TTM) was 3,043. Merck KGaA's current Cash Flow from Operations (TTM) was 4,075. ==> 4,075 > 3,043 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=10075.245/52497.1042
=0.19192001

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=9745.763/51103.379
=0.19070682

Merck KGaA's gearing of this year was 0.19192001. Merck KGaA's gearing of last year was 0.19070682. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=13514.722/9486.369
=1.42464646

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=12924.788/10078.39
=1.28242586

Merck KGaA's current ratio of this year was 1.42464646. Merck KGaA's current ratio of last year was 1.28242586. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Merck KGaA's number of shares in issue this year was 435.422. Merck KGaA's number of shares in issue last year was 434.063. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=13355.225/22630.075
=0.59015381

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=14391.835/23354.783
=0.61622645

Merck KGaA's gross margin of this year was 0.59015381. Merck KGaA's gross margin of last year was 0.61622645. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=22630.075/51414.195
=0.44015228

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=23354.783/51256.497
=0.45564532

Merck KGaA's asset turnover of this year was 0.44015228. Merck KGaA's asset turnover of last year was 0.45564532. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+1+0+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Merck KGaA has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Merck KGaA  (OTCPK:MKGAF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Merck KGaA Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA (Merck KGaA) Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA (Merck KGaA) Headlines

From GuruFocus

/C O R R E C T I O N -- EMD Serono/

By PRNewswire PRNewswire 05-14-2020